PETERSBURG, VA—Eleven months after Boehringer Ingelheim put its 219-acre campus on the market, it has found a buyer: UniTao Pharmaceuticals LLC, a subsidiary of Shanghai-based Tenry Pharmaceutical Co., Ltd., is acquiring the spread.
The company manufactures active pharmaceutical ingredients and it plans to invest $22.5 million in the facility to establish its operations at the site. This will follow Boehringer Ingelheim's more than $150 million investment in the 85-acre site since it started developing it in 2008.
The sale got a not-so-subtle nudge from Virginia Governor Terry McAuliffe, who met with company officials in Shanghai during his Asia Marketing Mission. The state competed against California and China for the project, which is expected to bring 376 new jobs to Petersburg. The city was aided by a $1 million grant from the Governor's Opportunity Fund.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.